Recently, Zhejiang Helianhealth Internet Technology Co., Ltd. (herein referred as "Helianhealth") announced the completion of series-B financing with amount of 75 million U.S. dollars, recording the highest single financing amount in the field of hospital innovation scenarios. This investment was led by Shenzhen SenseTime Technology Co., Ltd. (herein referred as SenseTime), a renowned artificial intelligence platform, and followed by a number of top-tier private equities, including Wanxiang Investment, and Hangzhou Newmargin Investment. Immediately upon this round of financing, Helianhealth stepped into the range of a unicorn company with a market valuation of nearly US$1 billion.
As the world's leading AI platform, SenseTime maintains the world's largest and most valued artificial intelligence unicorn company status. Through this strategic investment in Helianhealth, SenseTime will further expand the application channels of AI technology, and accelerate the integration of AI technology in hospital scenarios into practical use. SenseTime will accompany Helianhealth to deepen the layout of medial field, empower the hospital with innovative AI technology, and upgrade the medical industry through this strategic cooperation.
Llinks, as the legal counsel of SenseTime, advised this series-B financing of Helianhealth.
